First Alzheimer's drug to slow disease, Leqembi, gets full FDA approval
First Alzheimer's drug to slow disease, Leqembi, gets full FDA approval
www.cbsnews.com First Alzheimer's drug to slow disease, Leqembi, gets full FDA approval
Leqembi is not a cure, but it is the first drug shown to slow the progression of Alzheimer's disease. It first received an accelerated approval from the FDA earlier this year.
